Oregon State Drug Review


A monthly newsletter published by the College of Pharmacy on behalf of the P&T Committee. Provides drug utilization reviews, drug and therapeutic guideline reviews, and cost-effective prescribing recommendations to Medicaid providers and pharmacies throughout Oregon. Each newsletter is offered in PDF format for viewing and printing.

You may elect to receive the newsletter monthly via email subscription through the OSUPHARMDI Listserv.

Volume 6 - 2016

Issue   Table of Contents
No. 4, June 2016   Who Benefits from Calcium and Vitamin D Supplementation
No. 3, April 2016   Autism Spectrum Disorder Still Not Linked to the MMR Vaccine: A Review of the Studies since the 1998 Wakefield Study
No. 2, March 2016   Antidiabetic Treatments and Cardiovascular Implications
No. 1, February 2016   2015 in Review: Relevant Safety Updates and Ongoing Safety Concerns

Volume 5 - 2015

Issue   Table of Contents
No. 8, December 2015   Does Sacubitril/Valsartan Pose a Treatment Conundrum for Management of Heart Failure?
No. 7, November 2015   Obesity and Related Sequelae: Are Medications the Answer?
No. 6, October 2015   From Antidotes to Edoxaban: An Oral Anticoagulation Update
No. 5, August 2015   Is Long-Term Proton Pump Inhibitor Treatment for GERD Worth the Risk?
No. 4, June 2015   New Hypertension Guidelines: Do Blood Pressure Goals Need to Change with Age?
No. 3, May 2015   Treating UTIs with the Tried and True
No. 2, March 2015   Combating the Opioid Epidemic: Are Abuse-deterrent Formulations the Answer?
No. 1, February 2015   Evaluation of High Dose SSRI Initiation in Pediatrics and Young Adults

Volume 4 - 2014

Issue   Table of Contents
No. 8, November 2014   Guidance Update for Prophylaxis of Respiratory Syncytial Virus
No. 7, October 2014   What's New with Oral Anticoagulants?
No. 6, August 2014   New Hepatitis C Antiviral Therapies: How should they be used in clinical practice?
No. 5, June 2014   Update on New Therapies for Treating Major Depressive Disorder (MDD)
No. 4, May 2014   New Cholesterol Guidelines: A Significant Shift in Cholesterol Management
No. 3, April 2014   Second Generation Antipsychotics: Are these drugs effective in treating PTSD?
No. 2, March 2014   Evidence Based Review of Fish Oil: Going Beyond the Headlines
No. 1, January 2014   Strategies for Effective Monitoring and Management of Psychotropics in Children

Volume 3 - 2013

Issue   Table of Contents
No. 5, November 2013   Update on the New Oral Anticoagulants with a Focus on Apixaban
No. 4, October 2013   Updates and Comparisons of Type 2 Diabetes Treatment Guidelines
No. 3, August 2013   Managing Metabolic Side Effects in Children Receiving Antipsychotics
- Quick Reference Guides
No. 2, July 2013   Updates and Future Perspectives in the Management of Stable Chronic Obstructive Pulmonary Disease
No. 1, April 2013   Management of Gout in the Presence of Chronic Kidney Disease

Volume 2 - 2012

Issue   Table of Contents
No. 7, December 2012   The Future of Newer Obesity Medications
No. 6, September 2012   Do Spinosad or Ivermectin Have a Place in Head Lice Eradication?
No. 5, August 2012   Triple Therapy with the New Hepatitis C Protease Inhibitors: Challenges and Strategies
No. 4, June 2012   Can The Diabetic War Be Fought By Aggressive Blood Pressure Control?
No. 3, May 2012   Is Prasugrel or Ticagrelor a Better Choice Than the New Generic Clopidogrel?
No. 2, March 2012   Current Findings in the Off-Label Use of Atypical Antipsychotics
No. 1, January 2012   RSV Prophylaxis: Updates and Recommendations

Volume 1 - 2011

Issue   Table of Contents
No. 1, November 2011   Atypical Antipsychotic Drug Class Review

 

Past Issues of the DUR Board Newsletter:

Click Here

About the Oregon State Drug Review

We hope the Oregon State Drug Review newsletter is useful, thought provoking and interesting to our readers. Questions, concerns, comments, or suggestions are always welcome and should be addressed to the managing editor:

Kathy Sentena
OSU College of Pharmacy - Drug Use Research & Management @
OHA Division of Medical Assistance Programs
500 Summer Street NE, E35
Salem, OR 97301-1079
Phone: (503) 778-0014
Fax: 503-947-1119
sentenak @ ohsu.edu